-
Posted by
Two Blokes Jul 4 -
Filed in
Stock
-
2 views
Moderna (MRNA 0.66%), the next-generation healthcare company most famous for developing the Spikevax coronavirus vaccine, was an uncharacteristically popular stock. Investors piled into its shares over the week, sending it to a more than 12% gain over the period, according to data compiled by S&P Global Market Intelligence.
